Ondansetron Actiofarma

Medicinal product

(Invented) name

Ondansetron Actiofarma

Active substance (s)

Ondansetronas

Strength

8 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A04AA01, Ondansetron

Marketing authorisation holder

UAB Actiofarma, Lietuva

Date of authorisation

2020-02-28

Date of renewal

Documents

1217-001-002_Ondansetron Actiofarma_2021-04-22.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Ondansetronas	8 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103399	89501	1089501	lizdinė plokštelė	N10		Receptinis	LT/L/20/1217/001	Netiekiama	-	-	No	-	-	Download
103400	89502	1089502	lizdinė plokštelė	N20		Receptinis	LT/L/20/1217/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2020-02-28	Registruotas